检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:张俊伟[1] 李旭清[1] 陈磊 周薇 吕晶丽 郎华 杨璐 冯莉 王姝雅 胡睿 Zhang Junwei;Li Xuqing;Chen Lei;Zhou Wei;Lyu Jingli;Lang Hua;Yang Lu;Feng Li;Wang Shuya;Hu Rui(Department of Editorial Board,Shanxi Province Cancer Hospital,Shanxi Hospital Affiliated to Cancer Hospital,Chinese Academy of Medical Sciences,Cancer Hospital Affiliated to Shanxi Medical University,Taiyuan 030013,China)
机构地区:[1]山西省肿瘤医院,中国医学科学院肿瘤医院山西医院,山西医科大学附属肿瘤医院杂志社,太原030013
出 处:《肿瘤研究与临床》2022年第11期853-857,共5页Cancer Research and Clinic
摘 要:目的分析《白血病·淋巴瘤》载文情况,为期刊发展及更好地服务读者、作者提供参考。方法在期刊官网(www.bxblbl.com.cn)和中华医学期刊全文数据库(www.yiigle.com)检索《白血病·淋巴瘤》2019年1月至2021年12月刊载的所有论文,运用文献计量法、Excel软件对载文情况进行统计分析。根据中华医学期刊网出版平台期刊网站(https://app.yiigle.com/cmaapp/)数据进行网站阅读量及下载情况统计。结果2019年1月至2021年12月《白血病·淋巴瘤》共出版36期,载文合计578篇,期均载文量16篇。共刊登论著222篇(38.4%),短篇论著173篇(29.9%),指南与共识11篇(1.9%),专题综论58篇(10.0%),综述94篇(16.3%);作者合作度为5.10(2946/578)。发文第一作者单位属地包括28个省、市、自治区;发文量居前10位的地区分别为江苏、河南、北京、福建、山西、广东、天津、上海、河北、山东,共发文425篇(73.5%)。基金资助论文共有257篇(44.5%),其中国家级基金资助论文105篇(18.2%)。篇均引文量为18.6条(10751/578)。年平均阅读量为104630次,2021年度阅读量排名前20位的论文以指南与共识类及专题综论类居多。结论《白血病·淋巴瘤》近年来发展良好,在血液肿瘤领域中的影响力稳步提高。今后应根据办刊宗旨,进一步打造特色栏目,提高学术质量,更好地服务读者、作者。Objective To analyze the situation of articles published in Journal of Leukemia&Lymphoma and provide reference for the development of the journal and better service to readers and authors.Methods All articles published in Journal of Leukemia&Lymphoma from January 2019 to December 2021 were searched on the official website of the journal(www.bxblbl.com.cn)and the full-text database of Chinese medical journals(www.yiigle.com),and the statistical analysis of the articles published in the journal was performed using bibliometric methods and Excel software.Website readings and downloads were recorded based on data from the Chinese medical journal network publishing platform(https://app.yiigle.com/cmaapp/).Results From January 2019 to December 2021,36 issues of Journal of Leukemia&Lymphoma were published,containing a total of 578 articles,with an average of about 16 articles per issue.There were 222(38.4%)original articles,173(29.9%)brief communications,11(1.9%)guidelines and consensus articles,58(10.0%)topic reviews,and 94(16.3%)reviews;the degree of authorship cooperation was 5.10(2946/578).The first author's affiliation included 28 provinces,cities and autonomous regions.The top 10 regions were Jiangsu,Henan,Beijing,Fujian,Shanxi,Guangdong,Tianjin,Shanghai,Hebei,and Shandong,with a total of 425(73.5%)articles.There were 257(44.5%)funded articles,including 105(18.2%)articles funded by national funds.The average number of citations per article was 18.6(10751/578).The average annual number of reads was 104630,and the top 20 most-read articles in 2021 were mostly in the category of guidelines and consensus and topical reviews.Conclusions Journal of Leukemia&Lymphoma has developed well in recent years,and its influence in the field of hematology-oncology has steadily increased.In the future,according to the purpose of the journal,the special columns should be further created,and the academic quality should be improved to better serve the readers and authors.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.38